Skip to main content

Table 2 Summary of differences between groups on measures of general well-being

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Scale Author (total sample size; treatment vs. control) Difference* 95% CI
EUROQUOL Group 5-Dimension Report Questionnaire Descriptive Score Stott et al. [73] (638; 318 vs. 320) − 0.03* − 0.05 to 0.00 (p = 0.05)
EUROQUOL Group 5-Dimension Report Questionnaire Visual Analogue Scale Score Stott et al. [73] (638; 318 vs. 320) − 1.3* − 3.2 to 0.6
General Health Questionnaire Jorde et al. [63] (69; 36 vs. 33) 0.70* − 0.58 to 1.98
Medical Outcomes Study 36-item Short Form Health Survey Reuters et al. [72] (57; 25 vs. 32) 0.30** − 0.43 to 1.03
  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group